Ferguson Wellman Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-189,720
| Closed | -$6.63M | – | 377 |
|
|
2020
Q4 | $6.63M | Sell |
189,720
-184,200
| -49% | -$6.43M | 0.16% | 118 |
|
|
2020
Q3 | $13M | Buy |
373,920
+2,960
| +0.8% | +$103K | 0.36% | 74 |
|
|
2020
Q2 | $12.1M | Buy |
370,960
+7,986
| +2% | +$261K | 0.37% | 69 |
|
|
2020
Q1 | $10.9M | Buy |
362,974
+6,600
| +2% | +$199K | 0.41% | 65 |
|
|
2019
Q4 | $10.3M | Sell |
356,374
-7,886
| -2% | -$228K | 0.3% | 87 |
|
|
2019
Q3 | $9.42M | Buy |
364,260
+13,328
| +4% | +$345K | 0.3% | 90 |
|
|
2019
Q2 | $8.96M | Buy |
350,932
+158
| +0% | +$4.03K | 0.3% | 91 |
|
|
2019
Q1 | $9.17M | Buy |
350,774
+14,000
| +4% | +$366K | 0.31% | 87 |
|
|
2018
Q4 | $7.76M | Buy |
336,774
+13,740
| +4% | +$317K | 0.3% | 88 |
|
|
2018
Q3 | $7.61M | Buy |
+323,034
| New | +$7.61M | 0.25% | 98 |
|